Study guide

Surface tumours, uveal metastases and benign mimics

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

Surface tumours, uveal metastases and benign mimics

Key Takeaways Explain This Topic AI

OSSN ranges from epithelial dysplasia to invasive carcinoma, so depth and margins matter.

Clinical conjunctival pigmentation labels do not substitute for histological grading.

Choroidal metastases may be multifocal or bilateral and can reveal previously unrecognized systemic cancer.

Benign hamartomas, choristomas and vascular lesions can still cause major visual complications.

Last updated: October 2026

Describe growth, location and tissue involvement

An ocular mass may be epithelial, melanocytic, vascular, lymphoid, metastatic or developmental. Document its site, dimensions, pigmentation, vascularity, surface change and growth using examination and photographs. A pigmented lesion is not automatically melanoma, and an amelanotic lesion is not automatically benign. New nodularity, fixation, feeder vessels or corneal involvement can change the diagnostic priority.

Evert lids and examine fornices when assessing conjunctival disease. A visible bulbar lesion may be only part of the process. Anterior-segment optical coherence tomography can help define epithelial thickening, but it cannot reliably replace histology for all questions of invasion or tumour type. Plan sampling and treatment with an ocular oncology service when malignancy is suspected.

Ocular surface squamous neoplasia

Ocular surface squamous neoplasia (OSSN) encompasses epithelial dysplasia, in situ carcinoma and invasive squamous carcinoma. A limbal gelatinous, papilliform or leukoplakic lesion with corneal epithelial extension is suggestive, but pterygium, papilloma and other lesions can resemble it. Ultraviolet exposure and immune compromise are relevant risk factors without establishing the diagnosis in an individual.

Treatment can include a planned excision with margin assessment and selected cryotherapy, topical therapy or a combined approach. Topical agents include 5-fluorouracil, mitomycin C and interferon-based treatment where available and appropriate. Choice follows extent, suspected invasion, prior treatment and tolerance. Surface toxicity, punctal injury and limbal damage matter; do not present these agents as harmless drops or assume one regimen is universally available across Europe.

Visible regression does not remove the need for surveillance. A deep or atypical lesion may require tissue diagnosis even if an imaging pattern suggests epithelial disease. Recurrent disease and poor response should prompt reassessment of extent and diagnosis rather than indefinite repetition of the same course.

Conjunctival melanocytic lesions

A naevus often presents earlier in life and may contain cysts, commonly on bulbar conjunctiva. Acquired flat pigmentation has several causes, including melanocytic intraepithelial lesions with variable atypia. Clinical labels such as primary acquired melanosis do not by themselves specify the histological grade. Current pathology terminology and the report distinguish low- and high-grade intraepithelial disease and invasive melanoma.

Conjunctival melanoma can arise in different settings and can spread through lymphatic as well as haematogenous routes. Map extent, examine regional nodes and assess deeper involvement. A planned oncological excision differs from casually shaving a lesion at the slit lamp. Adjunctive treatment and surveillance depend on histology, margins, site and stage. Amelanotic melanoma remains in the differential of a suspicious fleshy mass.

  • Lesion category Key distinction Management implication
  • Epithelial atypia In situ versus stromal invasion Depth and margin assessment

Melanocytic pigmentation Benign lesion versus graded atypia or invasion Histological classification and mapping

  • Salmon-coloured infiltrate Reactive or lymphoid neoplasia Planned biopsy and systemic staging
  • Vascular fleshy mass Reactive granuloma or vascular tumour Clinical context and selective sampling
  • Uveal metastases and amelanotic lesions

Choroidal metastases often appear creamy or yellow and can be multifocal, bilateral or associated with subretinal fluid. Breast and lung malignancies are important primary sources, but an ocular lesion may precede recognition of the systemic tumour. Coordinate systemic investigation and oncology care. Do not assume that every solitary amelanotic choroidal lesion is a melanoma.

Ultrasound, OCT and selected angiography help characterize size, internal appearance and associated fluid. Differential diagnoses include melanoma, haemangioma, osteoma and inflammatory granuloma. Biopsy is selected when it will resolve an important uncertainty or guide care. Treatment may involve systemic cancer therapy, ocular radiotherapy or other local measures, chosen according to symptoms, visual potential and systemic prognosis.

Hamartomas, choristomas and vascular lesions

A hamartoma is disorganized overgrowth of tissue native to the site; a choristoma contains tissue not normally found there. A limbal dermoid is a choristomatous lesion and may affect refraction and cause amblyopia. Retinal astrocytic hamartomas can be associated with tuberous sclerosis but also occur in other settings. Retinal capillary haemangioblastomas raise consideration of von Hippel–Lindau disease according to age, number and systemic context.

Circumscribed choroidal haemangioma can cause exudation and visual loss, whereas diffuse choroidal haemangioma may occur with Sturge–Weber syndrome. Observation or treatment follows symptoms and anatomy. Benign histology does not mean a lesion cannot cause serious visual morbidity through exudation, glaucoma or refractive distortion.

Case response

A growing limbal leukoplakic mass needs OSSN assessment and a plan for invasion and margins. A new pigmented nodule requires a melanocytic differential with mapping. Bilateral creamy choroidal lesions require metastatic consideration and systemic coordination. State the tissue category, the uncertain feature and the investigation that changes treatment.

Sources: RCPath conjunctival melanoma dataset and primary OSSN treatment comparison .

Sections you finish are checked off in the contents.

  • Up Next
  • Paraneoplastic retinopathy, treatment effects and counselling
  • Continue learning